Cargando…

Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma

Deleted in Liver Cancer (DLC) proteins belong to the family of RhoGAPs and are believed to operate as negative regulators of the Rho family of small GTPases. So far, the role of the first identified member from the DLC family, DLC1, was established as a tumor suppressor in hepatocellular carcinoma....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolosz, Dominika, Walczak, Agnieszka, Szparecki, Grzegorz, Dwojak, Michal, Winiarska, Magdalena, Wolinska, Ewa, Gornicka, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383041/ https://www.ncbi.nlm.nih.gov/pubmed/30827083 http://dx.doi.org/10.4081/ejh.2019.2981

Ejemplares similares

Deleted in liver cancer 1 expression and localization in hepatocellular carcinoma tissue sections
por: WOLOSZ, DOMINIKA, et al.
Publicado: (2014)

Loss of the Orphan Nuclear Receptor SHP Is More Pronounced in Fibrolamellar Carcinoma than in Typical Hepatocellular Carcinoma
por: Wilczek, Ewa, et al.
Publicado: (2012)

Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma
por: Xiaorong, Li, et al.
Publicado: (2008)

The immunohistochemical analysis of membrane-bound CD55, CD59 and fluid-phase FH and FH-like complement inhibitors in cancers of ovary and corpus uteri origin
por: Kapka-Skrzypczak, Lucyna, et al.
Publicado: (2015)

Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
por: Wong, Carmen Chak-Lui, et al.
Publicado: (2008)

Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis
por: Yau, Tai On, et al.
Publicado: (2009)

Selection of an optimal promoter for gene transfer in normal B cells
por: Winiarska, Magdalena, et al.
Publicado: (2017)

Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma
por: XIE, CHENG-RONG, et al.
Publicado: (2015)

The RhoGAP protein Deleted in Liver Cancer 3 (DLC3) is essential for adherens junctions integrity
por: Holeiter, G, et al.
Publicado: (2012)

The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity
por: Basak, Pratima, et al.
Publicado: (2015)

Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma
por: Wolinska, Ewa, et al.
Publicado: (2021)

Endothelial DLC1 is dispensable for liver and kidney function in mice
por: Tan, Ying, et al.
Publicado: (2020)

Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function
por: Chan, Lo-Kong, et al.
Publicado: (2009)

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016)

DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016)

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1
por: Liao, Yi-Chun, et al.
Publicado: (2007)

Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo
por: Chan, Lo-Kong, et al.
Publicado: (2011)

CDK5 opens the way for DLC1
por: Short, Ben
Publicado: (2014)

Surface Reformation of Medical Devices with DLC Coating
por: Kaneko, Mao, et al.
Publicado: (2021)

Document Liveness Challenge Dataset (DLC-2021)
por: Polevoy, Dmitry V., et al.
Publicado: (2022)

Functional analysis of the Drosophila RhoGAP Cv-c protein and its equivalence to the human DLC3 and DLC1 proteins
por: Sotillos, Sol, et al.
Publicado: (2018)

Preliminary Study of Ge-DLC Nanocomposite Biomaterials Prepared by Laser Codeposition
por: Jelinek, Miroslav, et al.
Publicado: (2019)

Mechanotransduction in talin through the interaction of the R8 domain with DLC1
por: Haining, Alexander William M., et al.
Publicado: (2018)

Properties of titanium-alloyed DLC layers for medical applications
por: Joska, Ludek, et al.
Publicado: (2014)

Multifractal investigation of Ag/DLC nanocomposite thin films
por: Ţălu, Ştefan, et al.
Publicado: (2020)

Author Correction: Functional analysis of the Drosophila RhoGAP Cv-c protein and its equivalence to the human DLC3 and DLC1 proteins
por: Sotillos, Sol, et al.
Publicado: (2020)

Solution Structure of Tensin2 SH2 Domain and Its Phosphotyrosine-Independent Interaction with DLC-1
por: Dai, Kun, et al.
Publicado: (2011)

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics
por: ZIMONJIC, DRAZEN B., et al.
Publicado: (2012)

DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration
por: Lin, Yuan, et al.
Publicado: (2010)

The Role of Dlc1 Isoform 2 in K-Ras2(G12D) Induced Thymic Cancer
por: Sabbir, Mohammad Golam, et al.
Publicado: (2012)

DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017)

Synthesis of Multilayered DLC Films with Wear Resistance and Antiseizure Properties
por: Li, Yucheng, et al.
Publicado: (2021)

Improving frictional properties of DLC films by surface energy manipulation
por: Wang, Jia, et al.
Publicado: (2018)

Laser Structuring and DLC Coating of Elastomers for High Performance Applications
por: Vogel, Sönke, et al.
Publicado: (2022)

Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020)

Tribochemical Interactions between Graphene and ZDDP in Friction Tests for Uncoated and W-DLC-Coated HS6-5-2C Steel
por: Kowalczyk, Joanna, et al.
Publicado: (2021)

The tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell–cell adhesion
por: Vitiello, Elisa, et al.
Publicado: (2014)

DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway
por: Yang, Zheng, et al.
Publicado: (2019)

Impact of Perfluoro and Alkylphosphonic Self-Assembled Monolayers on Tribological and Antimicrobial Properties of Ti-DLC Coatings
por: Cichomski, Michal, et al.
Publicado: (2019)

DLC-1:a Rho GTPase-activating protein and tumour suppressor
por: Durkin, Marian E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_s4qugqkaekvgsn394epf4pfdub